Inventor · disambiguated record
Antitsa Dimitrova Stoycheva
Also filed as: STOYCHEVA ANTITSA · STOYCHEVA ANTITSA DIMITROVA
19 granted patents·17 pending applications·55 citations·filing 2008–2025
92Inventor score
Files withALIGOS THERAPEUTICS INC15INTERMUNE INC8JANSSEN BIOPHARMA INC7ALIOS BIOPHARMA INC5JANSSEN PHARMACEUTICA NV1
Top patents by PatentIndex Score
36 records- 0197US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 0293US9328119B2AZA-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2014·Granted May 3, 2016·15 cites·42 claims
- 0392US12018015B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·21 claims
- 0492US11952365B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·2 cites·18 claims
- 0590US11760761B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·26 claims
- 0690US10702523B2AZA-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Jul 7, 2020·3 cites·32 claims
- 0789US12065428B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·1 cites·23 claims
- 0889US11760764B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·24 claims
- 0987US10208045B2Aza-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·7 cites·39 claims
- 1086US10251882B2Aza-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2016·Granted Apr 9, 2019·4 cites·33 claims
- 1184US10793859B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2017·Granted Oct 6, 2020·2 cites·10 claims
- 1283US12077757B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2020·Granted Sep 3, 2024·1 cites·15 claims
- 1382US12252481B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1481US2025092400A1Modified Oligonucleotides and Methods of UseJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1579US10364226B2Pyridazinone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2014·Granted Jul 30, 2019·3 cites·36 claims
- 1678US10980805B2Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 20, 2021·0 cites·9 claims
- 1778US8048862B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2009·Granted Nov 1, 2011·3 cites·40 claims
- 1873US2021186969A1Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1969US2025243187A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2066US2024199647A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2165US2024018126A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2265US2023002409A1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2364US11312727B1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 26, 2022·0 cites·16 claims
- 2456US11845752B2Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis BALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·0 cites·21 claims
- 2555US2021317457A1Antisense oligonucleotide (aso) molecules and uses thereof for coronavirus diseasesALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2655US2022380770A1SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF FOR CORONAVIRUS DISEASESALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2753US2010119479A1Therapeutic antiviral peptidesINTERMUNE INC·Filed 2009·Application pending·0 cites
- 2852US2025368996A1Modified antisense oligonucleotides for treating hepatitis b virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2952US2009257979A1Novel Inhibitors of Hepatitis C Virus ReplicationINTERMUNE INC·Filed 2009·Application pending·0 cites
- 3051US2009047246A1Novel inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 3150US11787833B2Modified cyclic dinucleoside compounds as sting modulatorsALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 17, 2023·0 cites·18 claims
- 3244US2011059047A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
- 3342US2018179542A1OLIGONUCLEOTIDE TARGETING STRATEGY FOR cccDNAALIOS BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3438US2011110890A1Novel Inhibitors of Hepatitis C Virus ReplicationINTERMUNE INC·Filed 2010·Application pending·0 cites
- 3537US2011082182A1Therapeutic antiviral peptidesINTERMUNE INC·Filed 2010·Application pending·0 cites
- 3637US2011081315A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antitsa Dimitrova Stoycheva files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →